While a top variant identified by GWAS was assumed to regulate FTO by a series of functional tests in 2009–2010 [37, 38], in 2014 it was found to interact with the promoters of IRX3 located several hundred kilobases away and obesity-associated variants were associated with IRX3 expression [39]. This evidence concerns the gene IRX3 and obesity disorder.